investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Preclinical development of TIMP-2 as a biologic therapy for cancer

William Stetler-Stevenson

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Our goal is to study the effects of TIMP-2 and Ala+TIMP-2 on the growth of brain tumors in a syngeneic murine model by intracranial and/or systemic administration.

Related projects